Role of vascular endothelial growth factor antagonism on airway remodeling in asthma

Annals of Allergy, Asthma and Immunology

Volumn 110, Issue 3, 2013, Pages 150-155

  Yuksel, Hasan ^a   Yilmaz, Ozge ^a   Karaman, Meral ^b   Bagriyanik, H Alper ^b   Firinci, Fatih ^b   Kiray, Muge ^b   Turkeli, Ahmet ^a   Karaman, Ozkan ^b  

^a CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE; VASCULOTROPIN;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BASEMENT MEMBRANE; BRONCHUS MUCOSA; BRONCHUS MUSCLE; CELL COUNT; CONTROLLED STUDY; GOBLET CELL; HISTOPATHOLOGY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; THICKNESS;

AIRWAY REMODELING; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; ASTHMA; BASEMENT MEMBRANE; CELL COUNT; CHRONIC DISEASE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GOBLET CELLS; HUMANS; MAST CELLS; MICE; MICE, INBRED BALB C; MYOCYTES, SMOOTH MUSCLE; OVALBUMIN; RESPIRATORY MUCOSA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84875177771     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.12.015     Document Type: Article

References (28)

1. T. Doherty, and D. Broide Cytokines and growth factors in airway remodeling in asthma Curr Opin Immunol 19 2007 676 680
2. J.E. Allen, R.J. Bischof, and H.Y. Sucie Chang Animal models of airway inflammation and airway smooth muscle remodelling in asthma Pulm Pharmacol Ther 22 2009 455 465
3. I. Bara, A. Ozier, J.M. Tunon de Lara, R. Marthan, and P. Berger Pathophysiology of bronchial smooth muscle remodelling in asthma Eur Respir J 36 2010 1174 1184
4. A. Zanini, A. Chetta, A.S. Imperatori, A. Spanevello, and D. Olivieri The role of the bronchial microvasculature in the airway remodelling in asthma and COPD Respir Res 11 2010 132
5. M.V. Avdalovic, L.F. Putney, and E.S. Schelegle Vascular remodeling is airway generation-specific in a primate model of chronic asthma Am J Respir Crit Care Med 174 2006 1069 1076
6. K. Wang, C.T. Liu, Y.H. Wu, Y.L. Feng, and H.L. Bai Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma Adv Ther 25 2008 342 354
7. C. Bergeron, M.K. Tulic, and Q. Hamid Airway remodelling in asthma: from benchside to clinical practice Can Respir J 17 2010 e85 e93
8. J. Temelovski, S.P. Hogan, D.P. Shepher, P.S. Foster, and R.K. Kumar An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen Thorax 53 1998 849 856
9. R.J. McAnulty Models and approaches to understand the role of airway remodelling in disease Pulm Pharmacol Ther 24 2011 478 486
10. J.K. Burgess The role of the extracellular matrix and specific growth factors in the regulation of inflammation and remodelling in asthma Pharmacol Ther 122 2009 19 29
11. S. Al Heialy, T.K. McGovern, and J.G. Martin Insights into asthmatic airway remodelling through murine models Respirology 16 2011 589 597
12. D. Descalzi, C. Folli, and G. Nicolini Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts Allergy 63 2008 432 437
13. A. Chetta, A. Zanini, and A. Foresi Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone Am J Respir Crit Care Med 167 2003 751 757
14. E. Volonaki, S. Psarras, P. Xepapadaki, D. Psomali, D. Gourgiotis, and N.G. Papadopoulos Synergistic effects of fluticasone propionate and salmeterol on inhibiting rhinovirus-induced epithelial production of remodelling-associated growth factors Clin Exp Allergy 36 2006 1268 1273
15. N.J. Vanacker, E. Palmans, R.A. Pauwels, and J.C. Kips Dose-related effect of inhaled fluticasone on allergen-induced airway changes in rats Eur Respir J 20 2002 873 879
16. D. Ribatti, I. Puxeddu, E. Crivellato, B. Nico, A. Vacca, and F. Levi-Schaffer Angiogenesis in asthma Clin Exp Allergy 39 2009 1815 1821
17. N. Ferrara, K.J. Hillan, and W. Novotny Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy Biochem Biophys Res Commun 333 2005 328 335
18. S. Takahashi Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy Biol Pharm Bull 34 2011 1785 1798
19. B.N. Feltis, D. Wignarajah, and L. Zheng Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma Am J Respir Crit Care Med 173 2006 1201 1207
20. H.J. Freeman Colitis associated with biological agents World J Gastroenterol 18 2012 1871 1874
21. A. Chetta, A. Zanini, and A. Foresi Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma Clin Exp Allergy 35 2005 1437 1442
22. N.A. Hasaneen, S. Zucker, R.Z. Lin, G.G. Vaday, R.A. Panettieri, and H.D. Foda Angiogenesis is induced by airway smooth muscle strain Am J Physiol Lung Cell Mol Physiol 293 2007 L1059 L1068
23. D.E. Simcock, V. Kanabar, and G.W. Clarke Induction of angiogenesis by airway smooth muscle from patients with asthma Am J Respir Crit Care Med 178 2008 460 468
24. A.S. Kazi, S. Lotfi, and E.A. Goncharova Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent Am J Physiol Lung Cell Mol Physiol 286 2004 L539 L545
25. K.S. Lee, S.J. Park, and S.R. Kim Inhibition of VEGF blocks TGF-beta1 production through a PI3K/Akt signalling pathway Eur Respir J 31 2008 523 531
26. K. Asai, H. Kanazawa, H. Kamoi, S. Shiraishi, K. Hirata, and J. Yoshikawa Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients Clin Exp Allergy 33 2003 595 599
27. B.N. Feltis, D. Wignarajah, D.W. Reid, C. Ward, R. Harding, and E.H. Walters Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma Thorax 62 2007 314 319
28. F.Q. Wen, X. Liu, and W. Manda TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids J Allergy Clin Immunol 111 2003 1307 1318